Sulfadoxine/pyrimethamine

From WikiMD's WELLNESSPEDIA

Stauffer syndrome is a rare medical condition that is characterized by the presence of hepatomegaly (enlarged liver), jaundice (yellowing of the skin and eyes), and abnormal liver function tests. It is often associated with renal cell carcinoma, a type of kidney cancer. The syndrome was first described by Maurice H. Stauffer in 1961.

Symptoms[edit]

The symptoms of Stauffer syndrome can vary, but they often include:

Causes[edit]

Stauffer syndrome is often associated with renal cell carcinoma, a type of kidney cancer. However, the exact cause of the syndrome is not known. It is thought that the cancer cells may produce substances that affect the liver, leading to the symptoms of the syndrome.

Diagnosis[edit]

The diagnosis of Stauffer syndrome is usually made based on the presence of the characteristic symptoms and the association with renal cell carcinoma. Liver biopsy may be performed to confirm the diagnosis.

Treatment[edit]

The treatment of Stauffer syndrome involves treating the underlying renal cell carcinoma. This may involve surgery to remove the kidney tumor, as well as other treatments such as chemotherapy or radiation therapy. In some cases, the symptoms of Stauffer syndrome may improve or resolve after the kidney tumor is treated.

Prognosis[edit]

The prognosis for individuals with Stauffer syndrome depends on the stage and grade of the associated renal cell carcinoma. Early detection and treatment of the kidney cancer can improve the prognosis.

See also[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.